Could an mRNA vaccine second dose reduce cellular immunity in previously infected individuals?
As the pandemic of coronavirus disease 2019 (COVID-19) continues to spread the world over, the focus of scientific research has
Read moreAs the pandemic of coronavirus disease 2019 (COVID-19) continues to spread the world over, the focus of scientific research has
Read moreIgor Stagljar made his career building molecular tools to combat cancer. But when the pandemic hit last March, he aimed
Read moreSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative pathogen of the ongoing coronavirus disease 2019 (COVID-19) pandemic. The
Read moreApproximately 8 out of every 10 health professionals in Spain are willing to be vaccinated against COVID-19, according to a
Read moreResearchers from Skoltech were part of a research consortium studying a case of vertical COVID-19 transmission from mother to her
Read moreIn a recent editorial in the journal Emergent Materials, Dr. Huseyin C. Yalcin from Qatar University Biomedical Research Center and
Read moreThe coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally, with
Read moreA recent study by researchers in Switzerland found that the Pfizer-BioNTech mRNA vaccine had limited efficacy in identifying mutated receptor-binding
Read moreA brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy
Read moreResearchers from Cleveland Clinic's Florida Research and Innovation Center (FRIC) have identified a potential new target for anti-COVID-19 therapies. Their
Read more